<DOC>
	<DOCNO>NCT02690727</DOCNO>
	<brief_summary>This single centre , open label , randomize , two-treatment , two-period , two-sequence , single dose crossover food effect study 18 subject . The subject receive study medication either fed fast treatment period .</brief_summary>
	<brief_title>To Evaluate Food Effect Relative Bioavailability RP6530 Healthy Volunteers</brief_title>
	<detailed_description>The present study conduct healthy male volunteer . A single oral dose administer subject treatment period ( either fast fed state ) . Each treatment period separate least 7 calendar day . Post dose PK blood sample collect treatment period evaluate food effect bioavailability RP6530 . The safety tolerability single dose also evaluate .</detailed_description>
	<criteria>Healthy male volunteer ; age 18 45 year ; Body mass index ( BMI ) 18.0 30.0 kg/m2 inclusive , weight â‰¥ 50 kg ; Non smokers exsmokers ; Able give inform consent . Subjects evidence history clinically significant disease ; Positive result HIV Ag/Ab Combo , Hepatitis B surface Antigen ( HBsAG ( B ) ( hepatitis B ) ) Hepatitis C Virus ( HCV ( C ) ) test ; Subjects receive investigational drug previous 28 day ; Subjects participate study PI3k inhibitor least past year ; Subjects receive drug metabolise CYP3A4 enzyme previous 28 day .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Fasting</keyword>
	<keyword>Fed condition</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>